Erythrophagocytic T gamma lymphoma: a clinicopathologic entity resembling malignant histiocytosis.

PubWeight™: 1.48‹?› | Rank: Top 4%

🔗 View Article (PMID 6969851)

Published in N Engl J Med on March 12, 1981

Authors

M E Kadin, M Kamoun, J Lamberg

Articles citing this

Hemophagocytic syndromes and infection. Emerg Infect Dis (2001) 4.94

An ultrastructural study of subacute necrotizing lymphadenitis. Am J Pathol (1982) 1.66

Necrotising lymphadenitis without granulocytic infiltration (Kikuchi's disease). J Clin Pathol (1985) 1.63

Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification. J Clin Pathol (1987) 1.59

Frequent immunoglobulin and T-cell receptor gene rearrangements in "histiocytic" neoplasms. Am J Pathol (1985) 1.07

The human homologue of Dictyostelium discoideum phg1A is expressed by human metastatic melanoma cells. EMBO Rep (2009) 1.06

Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes. J Mol Diagn (2000) 1.01

Is there truly a risk of lymphoma from biologic therapies? Dermatol Ther (2009) 0.96

Malignant histiocytosis of the intestine: report of three cases with immunological and cytochemical analysis. J Clin Pathol (1982) 0.93

Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas. Am J Pathol (1990) 0.89

Malignant histiocytosis complicating rheumatoid arthritis: report of four cases. J Clin Pathol (1986) 0.82

Large granular lymphocyte leukemia in F344 rats. Model for human T gamma lymphoma, malignant histiocytosis, and T-cell chronic lymphocytic leukemia. Am J Pathol (1985) 0.81

Pediatric hemophagocytic syndromes: a diagnostic and therapeutic challenge. Allergy Asthma Clin Immunol (2005) 0.79

Ultrastructural identification of neoplastic histiocytes--monocytes: an application of a newly developed cytochemical technique. Am J Pathol (1982) 0.76

X-linked lymphoproliferative syndrome. Clin Exp Immunol (2000) 0.75

Articles by these authors

Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer (1973) 4.66

Identification of a human T lymphocyte surface protein associated with the E-rosette receptor. J Exp Med (1981) 3.06

Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells. Mol Cell Biol (1986) 2.76

Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med (1994) 2.29

Mycosis fungoides palmaris et plantaris. Arch Dermatol (1995) 2.25

Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24

Isolated granulomas in Hodgkin's disease. N Engl J Med (1970) 2.10

Neonatal cerebellar medulloblastoma originating from the fetal external granular layer. J Neuropathol Exp Neurol (1970) 1.88

Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Intern Med (1985) 1.83

Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci U S A (1996) 1.75

Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin's disease. Cancer (1971) 1.74

The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood (1996) 1.72

Enhanced expression of HLA antigens and beta 2-microglobulin on interferon-treated human lymphoid cells. Eur J Immunol (1979) 1.65

Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med (1992) 1.61

Epidemiology of lymphomatoid papulosis. Cancer (1992) 1.60

Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol (1998) 1.59

Possible origin of the Reed-Sternberg cell from an interdigitating reticulum cell. Cancer Treat Rep (1982) 1.51

Exogenous immunoglobulin and the macrophage origin of Reed-Sternberg cells in Hodgkin's disease. N Engl J Med (1978) 1.51

The pathology of large granular lymphocyte leukemia. Hum Pathol (1989) 1.44

Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells. J Exp Med (1992) 1.44

Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest (1997) 1.41

Stimulation of Fc gamma RIIIA results in phospholipase C-gamma 1 tyrosine phosphorylation and p56lck activation. J Exp Med (1992) 1.41

Laboratory medicine education in United States medical schools. Am J Clin Pathol (1993) 1.40

Expression of Hodgkin's disease associated antigen BLA.36 in anaplastic large cell lymphomas and lymphomatoid papulosis primarily of T-cell origin. Am J Clin Pathol (1995) 1.39

Suppression of interleukin 2 receptor acquisition by monoclonal antibodies recognizing the 50 KD protein associated with the sheep erythrocyte receptor on human T lymphocytes. J Immunol (1985) 1.38

γδ T-cell-rich variants of pityriasis lichenoides and lymphomatoid papulosis: benign cutaneous disorders to be distinguished from aggressive cutaneous γδ T-cell lymphomas. Br J Dermatol (2014) 1.38

Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol (1994) 1.34

Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol (1988) 1.33

Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood (1991) 1.32

Detection of clonal T-cell receptor gamma gene rearrangements in paraffin-embedded tissue by polymerase chain reaction and nonradioactive single-strand conformational polymorphism analysis. Am J Pathol (1999) 1.28

Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood (1986) 1.27

L-428 Reed-Sternberg cells and mononuclear Hodgkin's cells arise from a single cloned mononuclear cell. Int J Cell Cloning (1988) 1.26

Lymphoproliferative diseases in Japan and Western countries: Proceedings of the United States--Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. Hum Pathol (1983) 1.23

Prednisone in treatment of allergen-associated angio-immunoblastic lymphadenopathy. Lancet (1979) 1.20

A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma. Blood (1999) 1.19

A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas. J Immunol (1981) 1.19

The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia (1989) 1.16

T-cell intestinal lymphoma associated with celiac sprue. Ann Intern Med (1986) 1.13

Non-Hodgkin's lymphomas. II. Single agent chemotherapy. Cancer (1972) 1.12

Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia (2002) 1.12

Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma. Hum Pathol (1999) 1.12

Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies. Br J Haematol (1997) 1.10

Pathologic quiz case: Hepatic mass in a patient with renal cell carcinoma. Arch Pathol Lab Med (2001) 1.10

Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). Ann Oncol (1998) 1.09

A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol (1996) 1.09

Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature. Br J Dermatol (2003) 1.09

Phosphatidylinositol-3 kinase activation induced upon Fc gamma RIIIA-ligand interaction. J Exp Med (1994) 1.08

Letter: Origin of Hodgkin's cell. Lancet (1974) 1.07

Alveolar macrophages, blood monocytes, and density-fractionated alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen. Am Rev Respir Dis (1987) 1.07

A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol (1993) 1.07

Two regions within the human IL-2 gene promoter are important for inducible IL-2 expression. J Immunol (1988) 1.06

Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation. Hum Pathol (1997) 1.05

T-Cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases. Arch Dermatol (2000) 1.05

Common activated helper-T-cell origin for lymphomatoid papulosis, mycosis fungoides, and some types of Hodgkin's disease. Lancet (1985) 1.04

Cutaneous manifestations of postthymic T cell malignancies: description of five clinicopathologic subtypes. J Am Acad Dermatol (1990) 1.04

On the origin of Ewing's tumor. Cancer (1971) 1.04

Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomas. Genes Chromosomes Cancer (1998) 1.04

Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL). Blood (1997) 1.03

The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin's disease using fixed frozen tissues. Cancer (1989) 1.03

Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol (1990) 1.03

T gamma cells: a missing link between malignant histiocytosis and T cell leukemia-lymphoma? Hum Pathol (1981) 1.03

Center-defined unacceptable HLA antigens facilitate transplants for sensitized patients in a multi-center kidney exchange program. Am J Transplant (2014) 1.01

L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH. J Clin Invest (1988) 1.01

Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia. Lancet (1987) 1.01

Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes. J Mol Diagn (2000) 1.01

Intestinal pseudoobstruction caused by diffuse lymphoid infiltration of the small intestine. Gastroenterology (1985) 1.00

Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies. J Immunol (1985) 0.99

Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br J Haematol (1986) 0.99

Pesticide exposures in children with non-Hodgkin lymphoma. Cancer (2000) 0.97

Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy. J Exp Med (1996) 0.97

Ki-1/CD30+ (anaplastic) large-cell lymphoma: maturation of a clinicopathologic entity with prospects of effective therapy. J Clin Oncol (1994) 0.96

Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth. Am J Pathol (1988) 0.96

Primary cutaneous Hodgkin's disease. Unique clinical, morphologic, and immunophenotypic findings. Am J Dermatopathol (1994) 0.96

Glucocorticoid receptors in normal human eosinophils: comparison with neutrophils. J Allergy Clin Immunol (1981) 0.96

Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. Blood (1995) 0.96

Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications. Arch Dermatol (1996) 0.96

14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project. Tissue Antigens (2007) 0.95

Prognostic value of histologic and clinical factors in 56 patients with gastrointestinal lymphomas. Cancer (1988) 0.95

Macrophage-histiocytes in Hodgkin's disease. The relation of peanut-agglutinin-binding macrophage-histiocytes to clinicopathologic presentation and course of disease. Cancer (1985) 0.94

CD28-stimulated IL-2 gene expression in Jurkat T cells occurs in part transcriptionally and is cyclosporine-A sensitive. J Immunol (1992) 0.94

Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am J Surg Pathol (1998) 0.94

Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells. Exp Mol Pathol (2000) 0.94

Invasion of the brain by a cellular blue nevus of the scalp. A case report with light and electron microscopic studies. Cancer (1971) 0.94

[Simultaneous bilateral rhegmatogenous retinal detachment. 7 case studies]. J Fr Ophtalmol (2004) 0.93

Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Med Pediatr Oncol (2001) 0.93

Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (1997) 0.92

Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray. Am J Pathol (2001) 0.92

Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol (1996) 0.91

Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis. Cancer (1999) 0.91

[Evaluation of blood pressure control by ambulatory blood pressure monitoring and study of factors associated with poor blood pressure control in 300 treated hypertensive type 2 diabetic patients]. Ann Cardiol Angeiol (Paris) (2011) 0.91

Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients. Am J Transplant (2011) 0.91

Monoclonal antibodies recognizing human T cells: potential role for preventing graft-versus-host reactions following allogeneic marrow transplantation. Transplant Proc (1981) 0.91

Evaluation of splenectomy in large granular lymphocyte leukaemia. Br J Haematol (1987) 0.91

Reconstitution of an active surface CD2 by DNA transfer in CD2-CD3+ Jurkat cells facilitates CD3-T cell receptor-mediated IL-2 production. J Immunol (1991) 0.91

Is it lymphoma or lymphomatoid papulosis? J Am Acad Dermatol (1997) 0.90

Transfection of an Fc gamma receptor cDNA induces T cells to become phagocytic. Proc Natl Acad Sci U S A (1994) 0.90

C1.7 antigen expression on CD8+ T cells is activation dependent: increased proportion of C1.7+CD8+ T cells in HIV-1-infected patients with progressing disease. J Immunol (1999) 0.90

Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer. Clin Cancer Res (2000) 0.90

Immunologic markers in the differential diagnosis of small round cell tumors from lymphocytic lymphoma and leukemia. Am J Clin Pathol (1983) 0.90